Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neuroendocrine changes in chronic heart failure]

M Takác1, I Tkác, J Vancík

  • 1IV. interná klinika FNsP Kosice.

Vnitrni Lekarstvi
|March 1, 1993
PubMed
Summary

Neuroendocrine responses in chronic heart failure involve increased vasoconstrictor substances like noradrenaline (NA) and angiotensin II (AG II), overwhelming vasodilators such as atrial natriuretic factor (ANF).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An association between rs7635818 polymorphism located on chromosome 3p12.3 and the presence of abdominal aortic aneurysm.

Physiological research·2021
Same author

Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.

Clinical pharmacology and therapeutics·2016
Same author

A missense variant in GLP1R gene is associated with the glycaemic response to treatment with gliptins.

Diabetes, obesity & metabolism·2016
Same author

Circulatory and adipose tissue leptin and adiponectin in relationship to resting energy expenditure in patients with chronic obstructive pulmonary disease.

Physiological research·2012
Same author

Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.

Diabetes, obesity & metabolism·2012
Same author

Effects of hypoxia on adipose tissue expression of NFκB, IκBα, IKKγ and IKAP in patients with chronic obstructive pulmonary disease.

Cell biochemistry and biophysics·2012

Area of Science:

  • Cardiology
  • Endocrinology
  • Physiology

Context:

  • Chronic heart failure (CHF) presents complex neuroendocrine dysregulation.
  • Reduced cardiac output triggers compensatory vasoconstriction and hormonal imbalances.

Purpose:

  • To elucidate the neuroendocrine mechanisms underlying chronic heart failure.
  • To detail the interplay of vasoconstrictor and vasodilator substances in CHF pathophysiology.

Summary:

  • CHF elevates plasma noradrenaline (NA), renin, angiotensin II (AG II), arginine vasopressin (AVP), and endothelin, promoting vasoconstriction.
  • Compensatory vasodilators like atrial natriuretic factor (ANF) and dopamine are also involved but are ultimately overcome.
  • The balance shifts towards vasoconstriction, exacerbating CHF progression and receptor downregulation for ANF.

Impact:

  • Understanding these neuroendocrine pathways is crucial for developing targeted CHF therapies.
  • Highlights the imbalance between vasoconstrictive and vasodilative forces in heart failure progression.

Related Experiment Videos